Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Apr 15  •  01:50PM ET
14.19
Dollar change
+0.05
Percentage change
0.32
%
Apr 13, 7:05 AMInMode issues preliminary Q1 2026 results, guiding revenue to $81.5–$81.7 million and non-GAAP gross margin of 75%–76%
Index
-
P/E
9.81
EPS (ttm)
1.45
Insider Own
11.79%
Shs Outstand
63.36M
Perf Week
2.94%
Market Cap
898.76M
Forward P/E
9.26
EPS next Y
1.53
Insider Trans
0.00%
Shs Float
55.89M
Perf Month
5.62%
Enterprise Value
351.66M
PEG
-
EPS next Q
0.30
Inst Own
54.65%
Perf Quarter
1.11%
Income
93.83M
P/S
2.43
EPS this Y
-9.71%
Inst Trans
-4.66%
Perf Half Y
-7.29%
Sales
370.50M
P/B
1.32
EPS next Y
5.98%
ROA
12.09%
Perf YTD
-3.44%
Book/sh
10.78
P/C
1.62
EPS next 5Y
-3.23%
ROE
13.53%
52W High
16.74 -15.26%
Perf Year
-7.92%
Cash/sh
8.76
P/FCF
10.05
EPS past 3/5Y
-9.87% 6.62%
ROIC
13.63%
52W Low
12.72 11.52%
Perf 3Y
-61.33%
Dividend Est.
-
EV/EBITDA
4.09
Sales past 3/5Y
-6.57% 12.44%
Gross Margin
78.54%
Volatility
2.21% 2.12%
Perf 5Y
-67.52%
Dividend TTM
-
EV/Sales
0.95
EPS Y/Y TTM
-38.62%
Oper. Margin
23.05%
ATR (14)
0.33
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
8.61
Sales Y/Y TTM
-6.16%
Profit Margin
25.33%
RSI (14)
58.91
Dividend Gr. 3/5Y
- -
Current Ratio
9.88
EPS Q/Q
-62.92%
SMA20
3.41%
Beta
2.04
Payout
0.00%
Debt/Eq
0.01
Sales Q/Q
6.13%
SMA50
1.69%
Rel Volume
0.43
Prev Close
14.14
Employees
660
LT Debt/Eq
0.01
SMA200
-2.18%
Avg Volume
1.12M
Price
14.19
IPO
Aug 08, 2019
Option/Short
Yes / Yes
Trades
Volume
331,789
Change
0.32%
Date Action Analyst Rating Change Price Target Change
Apr-29-25Downgrade BTIG Research Buy → Neutral
Apr-28-25Downgrade Robert W. Baird Outperform → Neutral $22 → $16
Oct-17-24Initiated BTIG Research Buy $25
Jul-23-24Downgrade Jefferies Buy → Hold $21 → $19
Nov-03-23Downgrade UBS Buy → Neutral $52 → $24
Oct-13-23Downgrade Canaccord Genuity Buy → Hold $55 → $22
Mar-29-23Initiated UBS Buy $40
Feb-17-23Downgrade Needham Buy → Hold
Dec-21-22Initiated Barclays Overweight $44
Oct-12-22Initiated Jefferies Buy $40
Apr-13-26 07:00AM
Mar-24-26 08:30AM
Mar-13-26 07:00AM
Feb-26-26 08:00AM
Feb-23-26 10:32AM
07:00AM Loading…
07:00AM
Feb-10-26 04:32PM
04:02PM
03:50PM
07:23AM
07:00AM
Feb-03-26 08:00AM
Feb-02-26 07:00AM
Jan-30-26 04:53PM
Jan-29-26 12:44PM
05:30PM Loading…
Jan-28-26 05:30PM
Jan-26-26 03:34PM
Jan-08-26 07:00AM
Nov-07-25 04:00AM
Nov-05-25 07:14AM
07:00AM
Nov-04-25 08:08AM
Nov-03-25 08:05AM
Oct-30-25 08:30AM
Oct-09-25 07:00AM
Oct-07-25 05:39AM
Sep-09-25 08:15AM
Sep-03-25 11:34AM
Sep-02-25 08:30AM
Aug-05-25 08:30AM
08:10AM Loading…
Jul-30-25 08:10AM
07:08AM
07:00AM
Jul-29-25 09:51AM
Jul-25-25 10:31AM
Jul-24-25 10:00AM
Jul-23-25 10:00AM
Jul-16-25 09:39AM
Jul-10-25 07:00AM
May-28-25 08:30AM
May-23-25 10:26AM
May-20-25 09:19AM
May-09-25 08:22AM
May-07-25 08:30AM
May-06-25 08:03AM
Apr-29-25 07:00AM
05:57AM
03:02AM
01:52AM
Apr-28-25 11:53AM
08:25AM
07:25AM
07:00AM
Apr-24-25 10:01AM
Apr-21-25 10:00AM
Apr-14-25 07:00AM
Apr-10-25 11:36AM
Apr-03-25 04:26AM
Mar-27-25 05:00AM
Mar-26-25 11:44AM
08:30AM
Mar-25-25 09:40AM
Mar-06-25 07:30AM
Mar-03-25 08:30AM
Feb-06-25 06:00PM
Feb-05-25 07:10AM
02:08AM
Feb-04-25 07:16AM
07:00AM
Feb-03-25 08:30AM
Jan-29-25 09:48AM
Jan-16-25 07:00AM
Jan-15-25 08:05AM
Jan-08-25 07:00AM
07:00AM
Dec-10-24 10:53PM
Nov-06-24 08:30AM
Oct-31-24 07:29AM
03:07AM
01:25AM
Oct-30-24 03:45PM
08:10AM
07:07AM
07:00AM
Oct-29-24 09:11AM
Oct-24-24 07:03AM
Oct-23-24 10:01AM
Oct-14-24 09:40AM
Oct-13-24 05:25PM
Oct-10-24 07:00AM
Oct-09-24 03:42PM
Oct-02-24 07:28AM
Oct-01-24 07:00AM
Sep-26-24 09:40AM
Sep-23-24 05:34AM
Sep-10-24 09:40AM
07:00AM
Sep-04-24 08:30AM
Sep-01-24 11:27PM
Aug-14-24 11:05AM
InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. It also designs, develops, manufactures and markets non-invasive medical aesthetic products that target a array of procedures including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture and superficial benign vascular and pigmented lesions. The company was founded by Moshe Mizrahy and Michael Kreindel on January 2, 2008 and is headquartered in Yokneam, Israel.